Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Educational Status × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 8 Prostatic Neoplasms 5 Breast Neoplasms 5 Colorectal Neoplasms 3 Pancreatic Neoplasms 2 Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Malignant Solid Neoplasm 2 Uveal Melanoma 1 Skin Carcinoma 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Overweight 1 Ovarian Neoplasms 1 Obesity 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Malignant Solid Neoplasm 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematopoietic and Lymphoid System Neoplasm 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Esophageal Neoplasms 1

Interventions

pembrolizumab 14 Nivolumab 9 Gemcitabine 9 Specimen Handling 8 Carboplatin 8 enfortumab vedotin 7 Magnetic Resonance Spectroscopy 7 Cisplatin 7 Docetaxel 5 sacituzumab govitecan 4 atezolizumab 4 durvalumab 3 avelumab 3 Taxes 3 Paclitaxel 3 Ipilimumab 3 tislelizumab 2 erdafitinib 2 cabozantinib 2 Radiosurgery 2 Platinum 2 CTLA-4 Antigen 2 zanidatamab 1 veliparib 1 urelumab 1 tremelimumab 1 tazemetostat 1 sapanisertib 1 relatlimab 1 olaparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡